Patent · US Active

Ansamycin formulations and methods of use thereof

US7947670B2 · kind B2 · utility

2Cited by
13References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 2007
Grant dateMay 24, 2011
Priority date
Expiry dateMar 29, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D225/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, are solid forms of geldanamycin analogs, pharmaceutical compositions comprising a geldanamycin analog and a crystallization inhibitor, methods of making and using such compositions. Additionally, provided are methods for the treatment of cancer, a neoplastic disease state and/or a hyperproliferative disorder, and methods of inhibiting Heat Shock Protein 90 (“Hsp90”).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.